INSYN2A

Chr 10

inhibitory synaptic factor 2A

Also known as: C10orf141, FAM196A, INSYN2

Predicted to be involved in inhibitory postsynaptic potential. Predicted to be active in GABA-ergic synapse and postsynaptic density. [provided by Alliance of Genome Resources, Jun 2026]

OMIMResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
2
Pubs (1 yr)
P/LP submissions
P/LP missense
0.38
LOEUF
Mechanism

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.38LOEUF
pLI 0.915
Z-score 3.34
OE 0.12 (0.050.38)
Highly constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
-0.12Z-score
OE missense 1.02 (0.931.12)
308 obs / 302.1 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.12 (0.050.38)
00.351.4
Missense OE?1.02 (0.931.12)
00.61.4
Synonymous OE?0.97
01.21.6
LoF obs/exp: 2 / 16.7Missense obs/exp: 308 / 302.1Syn Z: 0.26

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

INSYN2A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →